13+
Clinical Faculty
10+
Specialties
100%
Root-Cause Focus
Board
Certified Standard
ABOPM's Clinical Department unites a distinguished team of board-certified physician-educators across more than ten specialties. From regenerative medicine and gastroenterology to reproductive endocrinology, neuropsychiatry, and longevity medicine, our faculty bring deep subspecialty expertise directly into the curriculum — translating cutting-edge science into precision medicine frameworks that physicians can apply immediately in clinical practice.
Beyond diagnosis and treatment, our department trains clinicians in root-cause clinical reasoning — integrating genomic, inflammatory, metabolic, and microbiome data to move past symptom management toward the molecular and environmental drivers of disease. Each specialty is taught not in isolation, but as part of an interconnected systems framework that reflects the full complexity of human health.
Multi-omic cardiovascular risk profiling — moving beyond lipid panels to the genomic, metabolic, and inflammatory root causes of heart disease.
Molecular tumor profiling, liquid biopsy, and immuno-oncology — personalizing cancer care through genomic and multi-omic intelligence.
Microbiome science, gut-brain axis research, and genomic GI diagnostics — applying precision frameworks to the molecular drivers of digestive and inflammatory bowel disease.
Epigenetic clocks, telomere biology, and precision aging biomarkers — training physicians to intervene at the molecular level to extend healthspan and slow biological aging.
Precision neuroscience, psychiatric genomics, and neuroinflammation — applying multi-omic tools to decode and treat the molecular underpinnings of mental and neurological illness.
AI, network medicine, and integrative multi-omics — training physicians to model the full complexity of human biology and apply systems-level thinking to clinical decision-making.
Advanced biomarker screening and individualized risk reduction — shifting practice from reactive treatment to proactive, prevention-first medicine.
Systems-level analysis of autoimmune and inflammatory joint disease — targeting the immune and molecular drivers behind chronic rheumatological conditions.
Stem cell therapy, platelet-rich plasma, and biologics — applying regenerative science with precision medicine rigor to restore function and accelerate healing.
Exercise science, sleep medicine, and behavioral health within a precision framework — training physicians to optimize human performance and prevent chronic disease.
Multi-omic insights into hormonal health, fertility, and reproductive medicine — enabling individualized, root-cause reproductive care for every patient.
The Clinical Departments at ABOPM bring precision medicine to the bedside — equipping physicians across every specialty with the board-certified frameworks, diagnostic tools, and therapeutic strategies needed to deliver individualized, evidence-based care to every patient they serve.
Supporting precision medicine integration across internal medicine, oncology, endocrinology, cardiology, neurology, and beyond — providing specialty-specific board standards and clinical frameworks tailored to the complexity of each discipline.
Developing and maintaining rigorous, evidence-based board certification standards that define excellence in clinical precision medicine — ensuring physicians are equipped to apply the latest advances in diagnostics, biomarkers, and individualized therapeutics.
Advancing the careers of clinicians through interdisciplinary education, mentorship, and collaborative research — building a community of board-certified physicians dedicated to transforming patient outcomes through precision clinical practice.
"Precision medicine is not a single specialty — it is the future of every specialty. The Clinical Departments at ABOPM exist to ensure that every physician, in every field, has the knowledge and certification to deliver truly individualized care."
American Board of Precision Medicine · Clinical DepartmentsPrecision medicine is not confined to a single specialty or a single laboratory. It belongs at the bedside of every oncologist, cardiologist, endocrinologist, and neurologist — in every clinical encounter where the difference between a generic protocol and an individualized strategy determines the outcome. Board certification in precision clinical medicine is not a credential of the future — it is the standard of practice today.
ABOPM's Clinical Departments equip physicians across every specialty with the evidence-based frameworks, molecular diagnostic tools, and individualized therapeutic strategies needed to move beyond population averages and deliver care that is as unique as the patient in front of them.
By earning clinical department certification, physicians gain the power to:
Every specialty has a precision medicine frontier. The question is, are you leading it?
Precision clinical approaches consistently outperform population-based protocols in complex disease — delivering measurably better outcomes through individualized diagnosis, treatment selection, and molecular monitoring tailored to each patient.
Molecular diagnostics, liquid biopsy, pharmacogenomics, and AI-assisted treatment planning are entering every specialty — clinicians with precision medicine board certification will lead this transformation at the bedside and beyond.
Board certification from ABOPM marks you as the precision medicine leader in your specialty — a physician equipped to set institutional standards, lead multidisciplinary teams, and drive the evidence-based individualization of care.
Precision medicine is transforming every clinical discipline — oncology, cardiology, endocrinology, neurology, immunology, and beyond. Certification positions you at the forefront of individualized care in your field and across all of medicine.
Active research areas driving clinical precision medicine forward:
The precision medicine transformation is not confined to research laboratories — it is arriving at the bedside of every specialty. Biomarker-driven diagnosis, molecularly targeted therapy, and pharmacogenomics-guided prescribing are actively reshaping clinical standards across oncology, cardiology, endocrinology, neurology, and beyond.
The ABOPM Clinical Departments position physicians at the center of this transformation — equipping them with the molecular diagnostic literacy, evidence-based clinical frameworks, and board-certified credentials to lead precision medicine in their specialty and across their institution.
As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.
The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.
The ABOPM Precision Oncology Department trains physicians to integrate tumor genomics, liquid biopsy, immunoprofiling, and targeted therapeutics into individualized treatment strategies — moving beyond population averages to treat each cancer as the unique disease it is.
Visit Department PagePrecision Oncology sits at the core of ABOPM's mission because cancer is the clearest proof case for precision medicine itself: every tumor carries a distinct genomic signature, and treating it as generic disease rather than individual biology costs patients time, response, and survival.
By establishing a board-certified standard for interpreting tumor genomics, monitoring treatment response, and matching patients to targeted and immune therapies, ABOPM gives physicians a credentialed framework the field currently lacks — and positions the organization at the forefront of where oncology is headed.
Sets the Clinical Standard
Establishes a rigorous, board-certified benchmark for genomic-driven cancer care where none currently exists.
Anchors a $560B Field
Prepares physicians for the fastest-growing segment of precision medicine, where genomic-guided treatment is now standard of care.
Strengthens ABOPM's Credibility
Demonstrates the depth of ABOPM's multidisciplinary faculty and reinforces its standing with partners, grantors, and academic collaborators.
Comprehensive Genomic Profiling
Somatic mutation analysis, copy number alterations, gene fusions, and mutational signatures across all tumor types.
Liquid Biopsy & ctDNA Monitoring
Real-time treatment response monitoring, minimal residual disease detection, and early resistance identification.
Immune Microenvironment Analysis
TMB, MSI status, PD-L1 expression, and TIL infiltration to identify immunotherapy responders.
Resistance Mechanism Mapping
Identifying acquired resistance pathways and adapting therapeutic strategy before clinical progression.
Identify actionable somatic mutations, copy number alterations, and gene fusions across every tumor site.
Guide institutional precision cancer programs and complex genomic treatment decisions.
Use ctDNA analysis to detect minimal residual disease and adapt therapy in real time.
Identify which patients respond to checkpoint inhibitors vs. combination or alternative immune strategies.
Every tumor has a molecular story.
Are you trained to read it?
Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Discover how targeted therapies are transforming precision oncology by matching cancer treatments to genetic mutations, enabling more personalized and effective care. ...more
On the Frontier
July 15, 2026•9 min read

Discover how genomics, biomarkers, and precision cardiology help identify cardiovascular risk early and enable personalized prevention. ...more
Precision Medicine in Action
July 08, 2026•8 min read

Learn how targeted therapies match drugs to cancer-driving mutations, advancing precision oncology and improving treatment outcomes. ...more
Precision Oncology
July 01, 2026•9 min read
Subscribe to receive ABOPM insights, research updates, and educational resources delivered directly to your inbox.
© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.